Systematic Reviews and Meta- and Pooled Analyses Pelvic In fl ammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies
Systematic Reviews and Meta- and Pooled Analyses Pelvic In fl ammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies
复制标题
DOI:
--
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Christina B. Rasmussen;S. Kjaer;V. Albieri;E. Bandera;J. Doherty;E. Høgdall;P. Webb;S. Jordan;M. Rossing;K. Wicklund;M. Goodman;F. Modugno;K. Moysich;R. Ness;R. Edwards;J. Schildkraut;A. Berchuck;S. Olson;L. Kiemeney;L. Massuger;S. Narod;C. Phelan;H. Anton-Culver;A. Ziogas;A. Wu;C. Pearce;H. Risch;A. Jensen
中科院分区:
文献类型:
--
作者:
Christina B. Rasmussen;S. Kjaer;V. Albieri;E. Bandera;J. Doherty;E. Høgdall;P. Webb;S. Jordan;M. Rossing;K. Wicklund;M. Goodman;F. Modugno;K. Moysich;R. Ness;R. Edwards;J. Schildkraut;A. Berchuck;S. Olson;L. Kiemeney;L. Massuger;S. Narod;C. Phelan;H. Anton-Culver;A. Ziogas;A. Wu;C. Pearce;H. Risch;A. Jensen
In fl ammation has been implicated in ovarian carcinogenesis. However, studies investigating the association between pelvic in fl ammatory disease (PID) and ovarian cancer risk are few and inconsistent. We investigated the association between PID and the risk of epithelial ovarian cancer according to tumor behavior and histotype. We pooled data from 13 case-control studies, conducted between 1989 and 2009, from the Ovarian Cancer Association Consortium (OCAC), including 9,162 women with ovarian cancers, 2,354 women with borderline tumors, and 14,736 control participants. Study-speci fi c odds ratios were estimated and subsequently combined into a pooled odds ratio using a random-effects model. A history of PID was associated with an increased risk of borderline tumors (pooled odds ratio (pOR) = 1.32, 95% con fi dence interval (CI): 1.10, 1.58). Women with at least 2 episodes of PID had a 2-fold increased risk of borderline tumors (pOR = 2.14, 95% CI: 1.08, 4.24). No association was observed between PID and ovarian cancer risk overall (pOR = 0.99, 95% CI: 0.83, 1.19); however, a statistically nonsigni fi cantly increased risk of low-grade serous tumors (pOR = 1.48, 95% CI: 0.92, 2.38) was noted. In conclusion, PID was associated with an increased risk of borderline ovarian tumors, particularly among women who had had multiple episodes of PID. Although our results indicated a histotype-speci fi c association with PID, the association of PID with ovarian cancer risk is still somewhat uncertain and requires further investigation.